[Remote] Rare Disease Sales Specialist - Indianapolis IN at Axsome Therapeutics Inc

Remote

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Team-oriented, goal-directed, and ownership mindset
Thrives in a collaborative, high-performance environment
Demonstrates grit, resilience, and determination in the face of challenges
Continuously strives to improve through feedback and learning
Strong business and market acumen
Ability to translate insights into actionable strategies and call plans
Advanced selling skills to influence HCP behavior
Ability to communicate complex clinical data clearly and engagingly

Responsibilities

Serve as the business owner for your territory, developing and executing a strategic plan to achieve or exceed sales targets
Identify, engage, and educate key healthcare professionals (HCPs), including nephrologists, nurse practitioners, and clinic staff
Build and maintain deep relationships across community and academic centers to support appropriate patient identification and treatment
Analyze territory dynamics to uncover growth opportunities and inform regional strategies
Deliver compelling, compliant clinical presentations to educate HCPs on atacicept’s mechanism of action, efficacy, safety, and patient benefits
Execute in-office and regional educational initiatives to enhance disease awareness and treatment understanding
Apply advanced selling skills to influence HCP behavior, foster accountability, and create urgency around patient care
Partner cross-functionally with Field Reimbursement, Medical Affairs, and Patient Support teams to ensure seamless patient access
Model Vera’s values of accountability, integrity, and compassion in every interaction
Collaborate with regional and cross-functional colleagues to ensure “One Vera” alignment in the field
Share best practices and insights to strengthen collective performance
Provide real-time feedback from the field to inform marketing and access strategies
Deliver consistent, compliant operational excellence

Skills

Key technologies and capabilities for this role

SalesRare DiseasePharmaceutical SalesNephrologyProduct LaunchAccount ManagementKey Opinion LeadersBiotechnology

Questions & Answers

Common questions about this position

What is the location for the Rare Disease Sales Specialist role?

This information is not specified in the job description.

What compensation or salary is offered for this position?

This information is not specified in the job description.

What skills and qualities are ideal for the Rare Disease Sales Specialist?

The ideal candidate brings a team-oriented, goal-directed, and ownership mindset, thrives in a collaborative, high-performance environment, and demonstrates grit, resilience, determination, and a drive to improve through feedback and learning. Strong business and market acumen is also required to translate insights into actionable strategies.

What is the company culture like at Vera Therapeutics?

Vera's values are the cornerstone of the culture, inspiring daily actions from hiring to advancing the mission of improving treatments for immunological diseases. The environment is collaborative and high-performance, with a focus on team-oriented individuals who take ownership.

What makes a strong candidate for this Rare Disease Sales Specialist position?

A strong candidate is team-oriented, goal-directed with an ownership mindset, thrives in collaborative high-performance settings, shows grit and resilience, and has strong business acumen for territory management and HCP engagement, particularly with nephrologists.

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters

2012Year Founded

$430.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Performance Bonus

Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.

Potential delays in AXS-07 launch amid growing market anticipation.

Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.

AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.

Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.

Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.

Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI

Try Jobo Free